Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial).
Ressler JM, Plaschka M, Silmbrod R, Bachmayr V, Shaw LE, Silly T, Zila N, Stepan A, Kusienicka A, Tschandl P, Tittes J, Roka F, Haslik W, Petzelbauer P, Koenig F, Kunstfeld R, Farlik M, Halbritter F, Weninger W, Hoeller C. Ressler JM, et al. Among authors: plaschka m. Nat Cancer. 2025 Jan;6(1):51-66. doi: 10.1038/s43018-024-00879-x. Epub 2025 Jan 16. Nat Cancer. 2025. PMID: 39820126 Free PMC article. Clinical Trial.
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer.
Lalle G, Lautraite R, Bouherrou K, Plaschka M, Pignata A, Voisin A, Twardowski J, Perrin-Niquet M, Stéphan P, Durget S, Tonon L, Ardin M, Degletagne C, Viari A, Belgarbi Dutron L, Davoust N, Postler TS, Zhao J, Caux C, Caramel J, Dalle S, Cassier PA, Klein U, Schmidt-Supprian M, Liblau R, Ghosh S, Grinberg-Bleyer Y. Lalle G, et al. Among authors: plaschka m. J Exp Med. 2024 Jun 3;221(6):e20231348. doi: 10.1084/jem.20231348. Epub 2024 Apr 2. J Exp Med. 2024. PMID: 38563819 Free PMC article.
The NF-κB RelA transcription factor is not required for CD8+ T-cell function in acute viral infection and cancer.
Voisin A, Plaschka M, Perrin-Niquet M, Twardowski J, Boutemine I, Eluard B, Lalle G, Stéphan P, Bouherrou K, Tonon L, Pommier R, Ferrari A, Klein U, Wencker M, Baud V, Cassier PA, Grinberg-Bleyer Y. Voisin A, et al. Among authors: plaschka m. Front Immunol. 2024 Mar 5;15:1379777. doi: 10.3389/fimmu.2024.1379777. eCollection 2024. Front Immunol. 2024. PMID: 38504985 Free PMC article.
An in vivo avian model of human melanoma to perform rapid and robust preclinical studies.
Jarrosson L, Dalle S, Costechareyre C, Tang Y, Grimont M, Plaschka M, Lacourrège M, Teinturier R, Le Bouar M, Maucort-Boulch D, Eberhardt A, Castellani V, Caramel J, Delloye-Bourgeois C. Jarrosson L, et al. Among authors: plaschka m. EMBO Mol Med. 2023 Mar 8;15(3):e16629. doi: 10.15252/emmm.202216629. Epub 2023 Jan 24. EMBO Mol Med. 2023. PMID: 36692026 Free PMC article.
ZEB1 transcription factor promotes immune escape in melanoma.
Plaschka M, Benboubker V, Grimont M, Berthet J, Tonon L, Lopez J, Le-Bouar M, Balme B, Tondeur G, de la Fouchardière A, Larue L, Puisieux A, Grinberg-Bleyer Y, Bendriss-Vermare N, Dubois B, Caux C, Dalle S, Caramel J. Plaschka M, et al. J Immunother Cancer. 2022 Mar;10(3):e003484. doi: 10.1136/jitc-2021-003484. J Immunother Cancer. 2022. PMID: 35288462 Free PMC article.